Skip to main navigation
Skip to search
Skip to main content
Houston Methodist Scholars Home
Help & FAQ
Link opens in a new tab
Search content at Houston Methodist Scholars
Home
Experts
Research units
Research output
Prizes
PIM3 Kinase: A Promising Novel Target in Solid Cancers
Pinar Atalay, Bulent Ozpolat
Academic Institute
Houston Methodist
Weill Cornell Medical College
Research output
:
Contribution to journal
›
Review article
›
peer-review
12
Link opens in a new tab
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'PIM3 Kinase: A Promising Novel Target in Solid Cancers'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Phosphotransferase
100%
Tumor Growth
100%
Clinical Trial
66%
Malignant Neoplasm
66%
Breast Cancer
33%
Prostate Cancer
33%
Pancreas Cancer
33%
Immunosuppressive Agent
33%
Carcinogenesis
33%
Colon Carcinoma
33%
Molecular Target
33%
Abdominal Cancer
33%
Liver Cancer
33%
Therapy Resistance
33%
Protein Serine Threonine Kinase
33%
Keyphrases
Provirus
100%
Solid Cancer
100%
Tumor Metastasis
25%
Clinical Trials
12%
In Cancer
12%
Breast Cancer
12%
Prostate Cancer
12%
Radiation Therapy
12%
Oncogene
12%
Chemotherapy
12%
PIM-1
12%
Tumor Growth
12%
Tumor Progression
12%
Cancer Therapy
12%
Colon Cancer
12%
Liver-pancreas
12%
Phase I Clinical Trial
12%
Targeted Therapy
12%
Serine-threonine Kinase
12%
Hematological Cancer
12%
Endoderm
12%
Novel Therapeutic Targets
12%
FDA-approved Drugs
12%
Putative Drug Targets
12%
Liver Cancer
12%
Therapy Resistance
12%
Oncogenic Signaling
12%
Cancer Cell Proliferation
12%
PIM2
12%
Stomach Cancer
12%
In Vitro Cell Proliferation
12%
In Vivo Tumor Growth
12%
Pancreas Cancer
12%
Immunosuppressive Microenvironment
12%
Pim Kinase Inhibitor
12%